Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.3 EUR | +1.94% | 0.00% | -10.42% |
04:19pm | Genmab's Tisotumab Shows 'Encouraging' Antitumor Activity in Phase 2 Head, Neck Cancer Study | MT |
04:00pm | Transcript : Genmab A/S - Special Call |
- Stock Market
- Equities
- GMAB Stock
- GE91 Stock
- News Genmab A/S